Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma | NEJM
Non-Hodgkin Lymphoma of the Liver: A US Population-based Analysis
Progression-free survival and overall survival rates of DLBCL patients,... | Download Scientific Diagram
Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups | Blood Cancer Journal
Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial | Haematologica
Survival after progression in patients with follicular lymphoma: analysis of prognostic factors - ScienceDirect
Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study - eClinicalMedicine
Adult Non-Hodgkin Lymphoma Treatment (PDQ®)–Health Professional Version - NCI
Five-year overall and progression-free survival rates of Hodgkin... | Download Scientific Diagram
The Natural History of Initially Untreated Low-Grade Non-Hodgkin's Lymphomas | NEJM
Median Survival Time - an overview | ScienceDirect Topics
Frontiers | Treatment, Survival, and Prognosis of Advanced-Stage Natural Killer/T-Cell Lymphoma: An Analysis From the China Lymphoma Collaborative Group
Non-Hodgkin lymphoma - The Lancet
prognosis of non Hodgkin's lymphoma - Primary Care Notebook
Long‐term survivors of childhood, adolescent and young adult non‐Hodgkin lymphoma - Ehrhardt - 2019 - British Journal of Haematology - Wiley Online Library
A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era | Scientific Reports
Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial | Haematologica
Overall Survival of 3,315 Non-Hodgkin's Lymphoma (NHL) Patients... | Download Scientific Diagram
Overall survival for different subtypes of non-Hodgkin lymphoma | Download Scientific Diagram
Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16−/CD16 + monocyte ratio | Scientific Reports
Frontiers | Survival Trends in Patients Under Age 65 Years With Mantle Cell Lymphoma, 1995–2016: A SEER-Based Analysis
The Natural History of Initially Untreated Low-Grade Non-Hodgkin's Lymphomas | NEJM
Age-standardized incidence and mortality rates of Hodgkin's lymphoma... | Download Scientific Diagram
